Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KB Design & Promotion Ltd

KB Design and Promotion Limited was established in 1988, with over 20 years experience delivering global solutions for our clients.  Whilst specializing in delivering promotional products worldwide, we creatively source and supply a range of products, which promote your products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

KB Design & Promotion Ltd
10 Foundry Court, Foundry Lane, Horsham, West Sussex, RH13 5PY, United Kingdom
+44 (0)1403 262 499
Contact KB Design & Promotion Ltd
Website

 Latest Content from PMHub 

Porterhouse welcomes additional expertise to its creative team

Press Releases | May 28, 2020 | Porterhouse Medical Group

Porterhouse Medical Group is delighted to welcome Jenny Barrett into our growing creative team as a Senior Designer.Jenny has over 35 years of experience as a creative, having worked in...

Demand Diversity Podcast

Videos and Podcasts | May 28, 2020 | COUCH Health

The unacceptable lack of diversity among clinical research participants would suggest that we are.As we begin our campaign to demand diversity in the clinical research space, we invite you to...

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE

White Papers and Resources | May 26, 2020 | EPG Health

The art of delivering valuable customer journeys aligned to your key messages in 2020

Lucid Group are shortlisted in three categories for Communiqué 2020

Press Releases | May 25, 2020 | Lucid Group Communications Limited

Lucid’s talent for creating industry-leading programmes is clear to see as they celebrate three of its campaigns being shortlisted for Communiqué 2020, as well as making the finals forThe Real...

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa

White Papers and Resources | May 21, 2020 | OPEN Health

Ben Speller shares his thoughts on the value of disease specific congresses

Bedrock double up

Press Releases | May 19, 2020 | Bedrock Healthcare Communications

Bedrock selected as a finalist in two categories for 2020 Communiqué awards

OPEN Health use PR to support clinical trial recruitment

White Papers and Resources | May 19, 2020 | OPEN Health

International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2

Covid-19: what could it mean for the diabetic population?

White Papers and Resources | May 19, 2020 | Wilmington Healthcare

Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it

Taking the ‘free’ out of ‘freelance’ and bringing it in-house

Press Releases | May 18, 2020 | Lucid Group Communications Limited

In this month’s Smart Thinking blog on PMLive.com, Stephanie Wasek, now a permanent principal medical writer at Lucid Group, draws her experience to discuss the highs and lows of being...

OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds

White Papers and Resources | May 18, 2020 | OPEN Health

Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers